CELL LINES FOR THE STUDY OF KAPOSI'S SARCOMA AND SMOOTH MUSCLE CELLS
UCLA Technology Available For Licensing

Kaposi's sarcoma (KS) is a multi-focal neoplasm frequently associated with Human Immunodeficiency Virus infection. As many as 40% of patients with HIV infection will be afflicted with this tumor, which causes cosmetic deformity, morbidity and occasional death. KS cell lines are desirable tools for the investigation of KS properties and drug testing. However, KS lines are notoriously difficult to grow.

New cell lines from the skin and pulmonary lesions of patients with AIDS-related Kaposi's sarcoma have been developed at UCLA. These cell lines are much easier to grow and maintain than other reported KS lines. In addition, these KS cell lines secrete matrix and can be used as a monolayer to grow matrix-requiring cell lines.

Interestingly, the new cell lines have certain morphological and biochemical markers that suggest they may be useful as models for smooth muscle cells. As such, they promise to be valuable reagents for studies related to the pathogenesis of atherosclerosis.

Reference: UCLA Case No. 1991-531

For additional technical details and current licensing
availability, please contact the following UCLA office:

UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095-7231
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
Lead Inventor: Steven Miles

UCLA Technologies Available for Licensing
http://www.research.ucla.edu/tech

Copyright © 2000 The Regents of the University of California.

keywords: research technologies uclancd ucla technologies intellectual property patents technology transfer invention business card